Komori
Medical System Network (4350) · PolicyAdvanced

Minimum necessary holdings of cross-shareholdings and regular reviews of their rationale

First written in FY2019. 3 of 5 entries say "Advanced", first in FY2021. Latest entry: FY2026.

5entries
8years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseFirst statedFY2019AdvancedFY2021RestatedFY2022AdvancedFY2025 – FY20262019: 120192020: 020202021: 120212022: 120222023: 020232024: 020242025: 120252026: 12026
Same theme, other companies
Review of the Rationale for Holding Strategic ShareholdingsA theme 1490 companies write about · 1 as a headwind · 782 as a tailwind
Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 200 companies compared. The sentences above are computed from all 200.Comparing 200 of the theme's 1494 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2026AdvancedAnnual report

    「Regarding cross-shareholdings held at the end of the fiscal year, the Board of Directors meeting held on 21 May 2026 conducted a review based on the above criteria and the purpose of each holding, and confirmed that the shares were held for purposes consistent with the holding policy.」

    For cross-shareholdings, the appropriateness of each individual holding was reviewed at the Board of Directors meeting held on 21 May 2026. The disclosure also states that 1 unlisted issue was sold.
  2. FY2025AdvancedAnnual report

    「Regarding cross-shareholdings held at the end of the fiscal year, the Board of Directors meeting held on 20 May 2025 conducted a review based on the above criteria and the purpose of each holding, and confirmed that the shares were held for purposes consistent with the holding policy.」

    For cross-shareholdings, the appropriateness of each individual holding was reviewed at the Board of Directors meeting held on 20 May 2025, and consistency with the holding policy was confirmed.
  3. FY2022RestatedAnnual report

    「Regarding cross-shareholdings held at the end of the fiscal year, the Board of Directors meeting held on 20 May 2022 conducted a review based on the above criteria and the purpose of each holding, and confirmed that the shares were held for purposes consistent with the holding policy.」

    For cross-shareholdings, the Board of Directors' annual review of the appropriateness of holdings continues, and consistency with the holding policy was confirmed.
  4. FY2021AdvancedAnnual report

    「For cross-shareholdings, the Board of Directors reviews the appropriateness of holding each individual issue every fiscal year, based on the status of maintaining and strengthening business relationships, operating performance, the balance with the cost of capital, future prospects and other factors.」

    The disclosure states that the Board of Directors conducted an issue-by-issue review of cross-shareholdings for each fiscal year, providing greater specificity on the implementation of the policy.
  5. FY2019First statedAnnual report

    「Our basic policy is not to hold such shares except where there is a rational business or other management-related reason. Investment is limited to the minimum necessary, and holdings are reviewed as appropriate after considering their effects on enhancing corporate value and other factors.」

    A new policy was expressly stated for cross-shareholdings, limiting them to cases with a rational holding purpose, restricting investment to the minimum necessary and reviewing the appropriateness of holdings for each fiscal year.
Moved together

"Strengthening Store Development and Support for Physicians Opening Practices" moved the same way as this thread, in the same document, in 3 of its 5 moves.

333333★123456
  1. ★This thread
  2. 1Strengthening Store Development and Support for Physicians Opening Practices3×
  3. 2Scale expansion through M&A in the dispensing pharmacy business3×
  4. 3Promoting Generic Drug Use and Initiatives for Home Healthcare3×
  5. 4Expansion of the dispensing pharmacy store network3×
  6. 5Addressing healthcare ICT, including electronic medication notebooks3×
  7. 6Expansion of the Pharmaceutical Network3×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
Medical System Network's next results are scheduled for 2026-11-10. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.